PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma
Adrenocortical carcinomas (ACCs) are heterogeneous cancers associated with a very poor prognosis. The improvement of prognostic tools and systemic therapy are urgently needed. Targeting the immune system using checkpoint inhibitors such as PD1/PDL1 inhibitors is an attractive novel therapeutic strat...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2019-11-01
|
| Schriftenreihe: | OncoImmunology |
| Schlagworte: | |
| Online-Zugang: | http://dx.doi.org/10.1080/2162402X.2019.1655362 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|